Clinical Trial Update: Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating toripalimab with paclitaxel and cisplatin vs. placebo with the same chemotherapy in advanced or metastatic esophageal squamous cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy | Phase 3 | Status: COMPLETED | Results posted: 2024-05-02